introduction to the pharmacology of cns drugs

49
Introduction to the Pharmacology of CNS Drugs By Mohammad H. Farjoo, M.D, Ph.D Shahid Beheshti University of Medical Science

Upload: mohammad-hadi-farjoo-md-phd

Post on 08-May-2015

13.400 views

Category:

Health & Medicine


7 download

DESCRIPTION

The underlined words are hyperlinks; please click on them to see the whole presentation. Please tell me what you think about my slides, you can write to: [email protected]

TRANSCRIPT

Page 1: Introduction to the pharmacology of CNS drugs

Introduction to the Pharmacology of CNS Drugs

By Mohammad H. Farjoo, M.D, Ph.DShahid Beheshti University of Medical Science

Page 2: Introduction to the pharmacology of CNS drugs

Introduction Ion Channels & neurotransmitters Synaptic Potentials Sites of Drug Action Identification of Neurotransmitters Cellular Organization of the Brain Central Neurotransmitters

Introduction to the Pharmacology of CNS Drugs

Page 3: Introduction to the pharmacology of CNS drugs
Page 4: Introduction to the pharmacology of CNS drugs
Page 5: Introduction to the pharmacology of CNS drugs
Page 6: Introduction to the pharmacology of CNS drugs
Page 7: Introduction to the pharmacology of CNS drugs

All drugs with CNS effects act on specific receptors General anesthetics and alcohol may be exceptions Drugs are among the most important tools for

studying all aspects of CNS physiology From the mechanism of convulsions to the laying

down of long-term memory. Specific agonists that mimic natural transmitters and

antagonists are extremely useful in such studies.

Introduction

Page 8: Introduction to the pharmacology of CNS drugs

The actions of drugs with known clinical efficacy has led to unraveling the mechanisms of CNS diseases: Antipsychotic drugs on dopamine receptors => the

pathophysiology of schizophrenia. Effects of ligands on γ aminobutyric acid (GABA)

receptors => the pathophysiology of anxiety and epilepsy.

Introduction

Page 9: Introduction to the pharmacology of CNS drugs

Snake, scorpion, snail, bee, wasp, frog and even plant

toxins are very important in the study of CNS.

A genus of marine snail (Conus ) includes at least 500 different species.

Each species kills its prey with a venom that contains 50–200 different peptides or proteins.

There is little duplication of peptides among Conus species!

These toxins are excellent investigational tools for ion channels study.

Introduction

Page 10: Introduction to the pharmacology of CNS drugs
Page 11: Introduction to the pharmacology of CNS drugs

Ion Channels & neurotransmitters

The membranes of nerve cells contain two types of channels.

They are defined on the basis of the mechanisms controlling their gating: Voltage-gated Ligand-gated

Page 12: Introduction to the pharmacology of CNS drugs

Voltage-sensitive Na+ channel

Page 13: Introduction to the pharmacology of CNS drugs

Voltage-sensitive K+ channel

Page 14: Introduction to the pharmacology of CNS drugs
Page 15: Introduction to the pharmacology of CNS drugs

Neurotransmitters exert their effects on neurons by binding to two classes of receptor: Ligand-gated channels, or ionotropic

Their activation is brief (milliseconds) opening Involved in fast transmission in hierarchical pathways

Metabotropic receptors G protein-coupled Their effects last tens of seconds to minutes Involved in the diffuse neuronal systems in the CNS Affect two types of voltage-gated ion channels:

Calcium channels (for presynaptic inhibition) Potassium channels (for postsynaptic inhibition)

Ion Channels & neurotransmitters

Page 16: Introduction to the pharmacology of CNS drugs

Types of ion channels and neurotransmitter receptors in the CNS. A shows a voltage-gated channel in which a voltage sensor component of the protein controls the gating (broken arrow ) of the channel. B shows a ligand-gated channel in which the binding of the neurotransmitter to the ionotropic channel receptor controls the gating (broken arrow ) of the channel. C shows a G protein-coupled (metabotropic) receptor, which, when bound, activates a G protein that then interacts directly to modulate an ion channel. D shows a G protein-coupled receptor, which, when bound, activates a G protein that then activates an enzyme. The activated enzyme generates a diffusible second messenger, eg, cAMP, which interacts to modulate an ion channel.

Page 17: Introduction to the pharmacology of CNS drugs

Receptor-mediated channel opening

Page 18: Introduction to the pharmacology of CNS drugs

Receptor-activated channels

Page 19: Introduction to the pharmacology of CNS drugs

Amplification in signal transduction pathways

Page 20: Introduction to the pharmacology of CNS drugs

When an excitatory pathway is stimulated, a excitatory postsynaptic potential (EPSP) is recorded.

When an inhibitory pathway is stimulated, an inhibitory postsynaptic potential (IPSP) is produced.

There is also a second type of inhibition, presynaptic inhibition, which is axoaxonic.

Synaptic Potentials

Page 21: Introduction to the pharmacology of CNS drugs

Single synapse Many synapses

Threshold

Resting membrane potential = -70 mV

Excitatory Post Synaptic Potential (EPSP)

Page 22: Introduction to the pharmacology of CNS drugs

Threshold

Resting membrane potential = -70 mV

Inhibitory Post Synaptic Potential (IPSP)

Excitation Identical ExcitationInhibition

Page 23: Introduction to the pharmacology of CNS drugs

Inhibitoryinterneurone

Ach (nic)

Ach)nic(

GlycineIncreases Cl-

permeabilityMotor neurone

Motor axo

n

Disinhibition of inhibitory fibers can cause convulsion (e.g. Strychnine which blocks inhibitory substance Glycine)

Page 24: Introduction to the pharmacology of CNS drugs

Virtually all CNS drugs produce their effects by modifying some step in chemical synaptic transmission.

These transmitter-dependent actions can be divided into presynaptic and postsynaptic.

The selectivity of CNS drug action is based on the fact that: Different transmitters are used by different groups of

neurons. These transmitters are segregated into neuronal systems

that subserve broadly different CNS functions.

Sites of Drug Action

Page 25: Introduction to the pharmacology of CNS drugs
Page 26: Introduction to the pharmacology of CNS drugs

Identification of Neurotransmitters

Localization to prove that a suspected transmitter resides in the

presynaptic terminal of the pathway under study

Release To determine whether the substance is released from a

particular region

Synaptic Mimicry Application of the suspected substance should produce

a response that mimics the action of the transmitter released by nerve stimulation

Page 27: Introduction to the pharmacology of CNS drugs

Cellular Organization of the Brain

Hierarchical systems Sensory perception and motor control Has 2 types of neurons:

Relay or projection neurons Local circuit neurons

Nonspecific or Diffuse Neuronal Systems Contain one of the monoamines—norepinephrine,

dopamine, or serotonin

Page 28: Introduction to the pharmacology of CNS drugs

Central Neurotransmitters

Inhibitory Amino Acids Excitatory Amino Acids Acetylcholine Monoamines Peptides Nitric Oxide Histamine

Glycine, GABA

Dopamine, Norepinephrine and 5-hydroxytryptamine

Glutamate

Page 29: Introduction to the pharmacology of CNS drugs
Page 30: Introduction to the pharmacology of CNS drugs

Schematic diagram of a glutamate synapse. Glutamine is imported into the glutamatergic neuron (A) and converted into glutamate by glutaminase. The glutamate is then concentrated in vesicles by the vesicular glutamate transporter. Upon release into the synapse, glutamate can interact with AMPA and NMDA ionotropic receptor channels (AMPAR, NMDAR) in the postsynaptic density (PSD) and with metabotropic receptors (MGluR) on the postsynaptic cell (B). Synaptic transmission is terminated by active transport of the glutamate into a neighboring glial cell (C) by a glutamate transporter. It is synthesized into glutamine by glutamine synthetase and exported into the glutamatergic axon. (D) shows a model NMDA receptor channel complex consisting of a tetrameric protein that becomes permeable to Na+ and Ca2+ when it binds a glutamate molecule.

Page 31: Introduction to the pharmacology of CNS drugs
Page 32: Introduction to the pharmacology of CNS drugs
Page 33: Introduction to the pharmacology of CNS drugs
Page 34: Introduction to the pharmacology of CNS drugs
Page 35: Introduction to the pharmacology of CNS drugs
Page 36: Introduction to the pharmacology of CNS drugs

SummaryIn English

Page 37: Introduction to the pharmacology of CNS drugs

Thank youAny question?

Page 38: Introduction to the pharmacology of CNS drugs
Page 39: Introduction to the pharmacology of CNS drugs
Page 40: Introduction to the pharmacology of CNS drugs

GABA

Page 41: Introduction to the pharmacology of CNS drugs

EndorphineEnkephaline

Page 42: Introduction to the pharmacology of CNS drugs

EndorphineEnkephaline

Page 43: Introduction to the pharmacology of CNS drugs

Dopamine

Page 44: Introduction to the pharmacology of CNS drugs

Acetyl choline

Page 45: Introduction to the pharmacology of CNS drugs
Page 46: Introduction to the pharmacology of CNS drugs
Page 47: Introduction to the pharmacology of CNS drugs

NoradrenalinSerotonin

Page 48: Introduction to the pharmacology of CNS drugs

Noradrenaline

Page 49: Introduction to the pharmacology of CNS drugs